Operating profit before amortization: Clene Inc. (CLNN)
Can Clene Inc. (CLNN) survive without the support of industry behemoths? The answer lies in its eco-friendly approach to nanotechnology and strict testing ethics. The operating financial result confirms these ambitions, where the 0.00 mark serves as a key metric. This chart's dynamics are based on the creation of innovative therapies to combat sclerosis and ALS, filling vacant medical niches.
%20Operating%20profit%20EBITDA&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CLNN_-_Clene-Inc._-_Operating-profit-EBITDA "Clene Nanomedicine - CLNN Profit before interest, taxes and amortization (period 11/23/2025 - 11/10/2026) | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for Clene (CLNN)
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet net asset value indicators:
- business debt structure and liquidity details:
- earnings and market multiples details:
CLNN - Company Net Income|Expected Profit Clene Inc.|CLNN - Price to Earnings Ratio|Price to Future Earnings Ratio Clene Inc|CLNN - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Clene|CLNN - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months Clene|CLNN - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months clene.com|CLNN - Net earnings per share growth this year|Earnings growth forecast for next year Clene Inc.
Summary company analytics:CLNN - Clene Inc.
Clene Inc. focuses on creating innovative nanopharmaceuticals for the therapy of neurodegenerative diseases, investing significant resources into high-tech R&D. An analysis of the absolute cash result of operations allows for an assessment of the real cash flow from core activities net of depreciation, helping investors distinguish sustainable operational efficiency from temporary market fluctuations and identify the trend reversal point in a timely manner.
Competitor analysis for Clene Inc.
Biogen Idec (BIIB) - Profit before interest, taxes and amortization|NBIX - Profit before payment of interest, taxes and amortization|RGC (regencellbioscience.com) - Operating profit before amortization|AXSM: Operating profit EBITDA|Profit before interest, taxes and amortization ACADIA Pharma (ACAD)|Operating profit before deduction of amortization XENE|VKTX: Income before deduction of interest, taxes and amortization|Operating profit EBITDA SUPN|Operating income before deduction of amortization catalystpharma.com|Profit before payment of interest, taxes and amortization Denali Therapeutics Inc. DNLI|HRMY: Operating profit before amortization|Biohaven Pharmaceutical - Operating profit EBITDA|Amylyx Corp (AMLX) - Operating profit before deduction of amortization|TRVI (Trevi Therapeutics) - Operating profit before deduction of amortization|PRAX - Operating income before deduction of amortization|AVXL (Anavex Life Sciences Corp.) - Operating profit EBITDA|Operating profit before deduction of amortization CeriBell Inc (CBLL)|Profit before payment of interest, taxes and amortization Prothena Corp (PRTA)|Profit before payment of interest, taxes and amortization ALEC (alector.com)|Profit before payment of interest, taxes and amortization Annexon, Inc. ANNX|OMER: Operating profit before amortization|NGNE - Profit before payment of interest, taxes and amortization|ACIU (AC Immune S.A.) - Operating profit before amortization|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Operating profit before amortization NMRA|SCLX (Scilex Holding Company) - Operating profit EBITDA|Profit before interest, taxes and amortization tevogen.com TVGN|Operating profit before deduction of amortization ACOG (Alpha Cognition)|Operating profit EBITDA Cognition Therapeutics Inc. (CGTX)|Profit before payment of interest, taxes and amortization Inhibikase IKT|Income before deduction of interest, taxes and amortization SAVA|ASRT - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization Coya Therapeutics, Inc.|VTGN: Operating profit EBITDA|Operating profit before deduction of amortization Ovid Therapeutics|Profit before payment of interest, taxes and amortization Acumen Pharma|Profit before payment of interest, taxes and amortization CRVO|Operating profit EBITDA ATHE|PEPG - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Jupiter Neurosciences JUNS|RLMD: Operating profit before amortization|Annovis Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Grace Therapeutics, Inc.|AIFF (Firefly Neuroscience, Inc) - Operating profit before deduction of amortization|Klotho Neurosciences - Income before deduction of interest, taxes and amortization|NRSN (NeuroSense Therapeutics Ltd) - Operating profit EBITDA|Reviva Pharmaceuticals Holdings Inc. (RVPH) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization MetaVia Inc (MTVA)|NeurAxis Inc - Operating profit before amortization|Operating profit EBITDA HSDT (Helius Medical Technologies)|PASG - Operating profit before deduction of amortization|NEUP: Operating profit before deduction of amortization|Operating income before deduction of amortization Minerva Neurosciences Inc NERV|ATHA: Operating profit EBITDA|Operating profit before deduction of amortization Addex|Profit before payment of interest, taxes and amortization Alzamend Neuro Inc.|Profit before payment of interest, taxes and amortization CYCN|Profit before payment of interest, taxes and amortization Protagenic Therapeutics (PTIX)|pasitheaclinics.com - Operating profit before amortization|Profit before payment of interest, taxes and amortization Cortigent CRGT|ATXI: Operating profit before amortization|BCLI - Profit before payment of interest, taxes and amortization|CARA (caratherapeutics.com) - Operating profit before amortization|CHRO: Operating profit EBITDA|Profit before interest, taxes and amortization Eliem Therapeutics Inc. (ELYM)|Operating profit before deduction of amortization ITCI|Operating profit EBITDA Longboard|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|NKGN (nkgenbiotech.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|Neurotrope - Operating profit EBITDA|Trevena Inc (TRVN) - Operating profit before deduction of amortization|vigilneuro.com (VIGL) - Profit before payment of interest, taxes and amortization|WENA (anewmeds.com) - Profit before payment of interest, taxes and amortization|CERE (Cerevel Therapeutics, Inc.) - Operating profit EBITDA
